Straumann Holding AG

BATS-CHIXE:STMNZ Stock Report

Market Cap: CHF 20.3b

Straumann Holding Valuation

Is STMNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of STMNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 112.66
Fair Value
13.4% overvalued intrinsic discount
19
Number of Analysts

Below Fair Value: STMNZ (CHF127.75) is trading above our estimate of fair value (CHF112.66)

Significantly Below Fair Value: STMNZ is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STMNZ?

Key metric: As STMNZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for STMNZ. This is calculated by dividing STMNZ's market cap by their current earnings.
What is STMNZ's PE Ratio?
PE Ratio70.6x
EarningsCHF 287.88m
Market CapCHF 20.32b

Price to Earnings Ratio vs Peers

How does STMNZ's PE Ratio compare to its peers?

The above table shows the PE ratio for STMNZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average30.6x
SN. Smith & Nephew
36.9x19.8%UK£9.0b
NIOX NIOX Group
21.7x18.4%UK£234.0m
CTEC ConvaTec Group
39.8x18.6%UK£5.0b
EKF EKF Diagnostics Holdings
23.8xn/aUK£116.4m
STMNZ Straumann Holding
70.6x20.1%CHF 20.3b

Price-To-Earnings vs Peers: STMNZ is expensive based on its Price-To-Earnings Ratio (70.6x) compared to the peer average (30.6x).

Price to Earnings Ratio vs Industry

How does STMNZ's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies8PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: STMNZ is expensive based on its Price-To-Earnings Ratio (70.6x) compared to the European Medical Equipment industry average (32.8x).

Price to Earnings Ratio vs Fair Ratio

What is STMNZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STMNZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio70.6x
Fair PE Ratio51.2x

Price-To-Earnings vs Fair Ratio: STMNZ is expensive based on its Price-To-Earnings Ratio (70.6x) compared to the estimated Fair Price-To-Earnings Ratio (51.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst STMNZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 127.75
CHF 132.05
+3.4%
16.8%CHF 175.00CHF 90.00n/a19
Jan ’26CHF 114.00
CHF 131.00
+14.9%
16.9%CHF 175.00CHF 90.00n/a18
Dec ’25CHF 114.15
CHF 131.12
+14.9%
17.3%CHF 175.00CHF 90.00n/a17
Nov ’25CHF 116.25
CHF 133.82
+15.1%
16.3%CHF 175.00CHF 90.00n/a17
Oct ’25CHF 137.55
CHF 137.06
-0.4%
16.4%CHF 175.00CHF 90.00n/a18
Sep ’25CHF 126.10
CHF 134.83
+6.9%
16.9%CHF 175.00CHF 90.00n/a18
Aug ’25CHF 113.20
CHF 134.33
+18.7%
18.1%CHF 175.00CHF 90.00n/a18
Jul ’25CHF 113.05
CHF 134.39
+18.9%
18.4%CHF 175.00CHF 90.00n/a18
Jun ’25CHF 117.35
CHF 135.94
+15.8%
18.2%CHF 175.00CHF 90.00n/a18
May ’25CHF 124.75
CHF 138.67
+11.2%
18.4%CHF 175.00CHF 90.00n/a18
Apr ’25CHF 144.00
CHF 142.32
-1.2%
18.4%CHF 175.00CHF 90.00n/a19
Mar ’25CHF 143.00
CHF 134.22
-6.1%
17.7%CHF 168.00CHF 90.00n/a18
Feb ’25CHF 137.30
CHF 128.22
-6.6%
16.1%CHF 153.00CHF 90.00CHF 130.8518
Jan ’25CHF 135.50
CHF 125.41
-7.4%
15.2%CHF 150.00CHF 90.00CHF 114.0017
Dec ’24CHF 119.85
CHF 124.47
+3.9%
14.8%CHF 150.00CHF 90.00CHF 114.1517
Nov ’24CHF 105.50
CHF 131.99
+25.1%
16.8%CHF 167.00CHF 90.00CHF 116.2517
Oct ’24CHF 117.00
CHF 135.38
+15.7%
18.0%CHF 167.00CHF 90.00CHF 137.5516
Sep ’24CHF 134.00
CHF 136.82
+2.1%
17.7%CHF 167.00CHF 90.00CHF 126.1017
Aug ’24CHF 143.90
CHF 134.47
-6.6%
20.4%CHF 165.00CHF 82.00CHF 113.2017
Jul ’24CHF 145.40
CHF 133.76
-8.0%
21.1%CHF 165.00CHF 82.00CHF 113.0517
Jun ’24CHF 134.85
CHF 131.88
-2.2%
22.3%CHF 165.00CHF 82.00CHF 117.3516
May ’24CHF 133.90
CHF 124.87
-6.7%
21.4%CHF 160.00CHF 82.00CHF 124.7515
Apr ’24CHF 136.10
CHF 124.53
-8.5%
21.8%CHF 160.00CHF 82.00CHF 144.0015
Mar ’24CHF 124.25
CHF 120.43
-3.1%
21.2%CHF 158.00CHF 80.00CHF 143.0014
Feb ’24CHF 121.30
CHF 116.21
-4.2%
20.4%CHF 150.00CHF 80.00CHF 137.3014
Analyst Price Target
Consensus Narrative from 19 Analysts
CHF 132.26
Fair Value
3.4% undervalued intrinsic discount
19
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/04 09:05
End of Day Share Price 2025/02/04 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Straumann Holding AG is covered by 48 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hassan Al-WakeelBarclays
Robert BateBarclays
Samuel EnglandBerenberg